NCT05612204Completed
Evaluation of Targeted Prostate Biopsies Under MRI: Tolerance and Contribution in the Therapeutic Decision - Exploratory Study
Source: ClinicalTrials.gov · Last updated 20 Aug 2026
Brief summary (registry, in English)
The goal of this clinical trial is to assess the concordance of treatment decisions made in multidisciplinary consultation meeting based on targeted biopsies alone or targeted biopsies associated with systematic biopsies in patients with suspected prostate cancer.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 51 (actual)
- First submitted
- 3 Nov 2022
- Start date
- 21 Nov 2022
- Primary completion date
- 30 Jun 2024
- Lead sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche
- Diseases
- Prostate cancer
- NCT number
- NCT05612204
What you commit to
- Study type: Interventional
- Participants enrolled: 51
- From 21 Nov 2022 to the primary completion date, 30 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient with a contraindication to MRI
- Patient with multiple targets
- Patient with lesions with PI-RADS score 1 and 2
- Patient on long-term anticoagulants and unable to stop it
- Patient already included in another study
- Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
- Patient hospitalized without consent
Who the study is looking for
- Patient, male, aged between ≥ 50 and ≤ 75 years old
- Patient with no history of prostate biopsy
- Patient with a PSA greater than 4 and/or a pathological digital rectal examination
- Patient having an MRI of interpretable quality carried out within the HPA
- Patient with a single lesion with a PI-RADS score ≥ 3
- Affiliated patient or beneficiary of a social security scheme
- French-speaking patient who signed an informed consent
Age in the registry: 50 years to 75 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| HPA Coordinator of this site? Confirm its status | Antony | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.